Safety and Preliminary Clinical Activity of Itolizumab in ARDS

Clinical trial NCT05978544 · UNKNOWN

Trial details

NCT number: NCT05978544
Sponsor: Biotech Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome

Start date: 2023-12-31
Primary completion: 2025-11-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.